Chronic renal diseases as a public health problem: epidemiology, social, and economic implications.

The impact of chronic kidney disease (CKD) on the global burden of diseases is probably underestimated by current methods of evaluation. However, CKD are emerging as a major health problem. First, the costs of renal replacement therapy are excedingly high and are consuming a significant proportion of health care budgets of developed countries, while in developing countries are out of reach. Second, complex interaction are clearly emerging between chronic kidney, cardiovascular disease, and diabetes.

[1]  R. Barsoum,et al.  End-stage renal disease in North Africa. , 2003, Kidney international. Supplement.

[2]  E. Jones,et al.  Epidemiological data of treated end-stage renal failure in the European Union (EU) during the year 1995: report of the European Renal Association Registry and the National Registries. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  S. Naicker,et al.  End-stage renal disease in sub-Saharan and South Africa. , 2003, Kidney international. Supplement.

[4]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[5]  A. Collins,et al.  Projecting the number of patients with end-stage renal disease in the United States to the year 2015. , 2005, Journal of the American Society of Nephrology : JASN.

[6]  G. Eknoyan,et al.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  M. Wiedemann,et al.  Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  Fatema Jawad,et al.  Renal transplantation in developing countries. , 2003, Kidney international. Supplement.

[9]  R. Barsoum.  Overview: end-stage renal disease in the developing world. , 2002, Artificial organs.

[10]  A. Torres,et al.  Heart valve calcification and calcium x phosphorus product in hemodialysis patients: analysis of optimum values for its prevention. , 2003, Kidney international. Supplement.

[11]  Simona Gioberge,et al.  ESRD patients in 2001: global overview of patients, treatment modalities and development trends. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  F. Luft,et al.  Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCA. , 2003, Kidney international.

[13]  B. Rutkowski,et al.  Changing pattern of end-stage renal disease in central and eastern Europe. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  K. Sud,et al.  End-stage renal disease in India and Pakistan: burden of disease and management issues. , 2003, Kidney international. Supplement.